April 4, 2013

10:30 Thrombosis and antithrombotic drugs in acute coronary syndromes
  Steen Dalby Kristensen (DK), Robert F. Storey (UK)
  • Current antiplatelet options in acute coronary syndromes (A.Parkhomenko)
  • Current options of anticoagulation in acute coronary syndromes (S Dalby Kristensen)
  • Pharmacogenetics and drug interactions with clopidogrel: testing or monitoring (RF Storey)
  • A critical comparison of new alternative treatment options (R. De Caterina)
13:00 Lunch Break

Long-term primary and secondary prevention of cardiovascular events  with antithrombotic drugs

  Lina Badimon (E), Sergio Coccheri (I)
  • Natural history of the athero-thrombotic plaque in different arterial districts (L. Badimon)
  • Aspirin in primary prevention: lights, shadows, and areas of uncertainty (S. Coccheri)
  • Antithrombotics in secondary   prevention strategy in high cardiovascular risk patients  (V.Netiazhenko)
  • Adding an anticoagulant to dual antiplatelet therapy (R. De Caterina)
16:30 Clinical cases
18:30 Dinner


April 5, 2013

08:30 Prophylaxis  and treatment of venous thromboembolism
  Grigori T Gerotziafas (F), Sabine Eichinger (A)
  • Prophylaxis and treatment of VTE in medical patients (GT Gerotziafas)
  • Clinical suspicion and diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) (Y.Lutay)
  • Trends and perspectives in the treatment of DVT: acute phase and secondary prevention (S. Eichinger)
  • Risk stratification in acute PE and related therapeutic options (L.Chernuha)
11:00 Coffee Break
11:30 Systemic cardiogenic thromboembolism and stroke
  Alexander Parkhomenko (UA), Raffaele De Caterina (I)
  • Assessment and stratification of thromboembolic risk in cardiac patients (atrial fibrillation, valvular heart disease and heart failure) (G.Dzyak)
  • Atrial septal aneurism, patent foramen ovale and paradoxical embolism, diagnosis and treatment options (SD Kristensen)
  • “Upstream therapy” in atrial fibrillation: does it decrease the cardioembolic risk? (O.Sychov)
  • Prevention of cardioembolism with traditional and new anti-thrombotics (R. De Caterina)
14:00 Conclusion remarks and closing of the meeting

Joint working session of the Ukrainian Association of Cardiology and the International Society on Thrombosis and Haemostasis (ISTH), the Mediterranean League on Thromboembolic Disease (MLTD)